A new trading day began on Friday, with Moderna Inc (NASDAQ: MRNA) stock price up 3.88% from the previous day of trading, before settling in for the closing price of $25.01. MRNA’s price has ranged from $22.28 to $48.92 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -42.94%. Meanwhile, its annual earnings per share averaged 12.72%. With a float of $346.57 million, this company’s outstanding shares have now reached $391.00 million.
Moderna Inc (MRNA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Moderna Inc is 11.30%, while institutional ownership is 70.20%. The most recent insider transaction that took place on Jun 11 ’25, was worth 8,736. In this transaction Director of this company sold 312 shares at a rate of $28.00, taking the stock ownership to the 580 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 312 for $28.00, making the entire transaction worth $8,736.
Moderna Inc (MRNA) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.91 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.87% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Here are Moderna Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.06, a number that is poised to hit -2.64 in the next quarter and is forecasted to reach -6.81 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
The latest stats from [Moderna Inc, MRNA] show that its last 5-days average volume of 8.19 million was inferior to 10.9 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 92.36%.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 27.80%, which indicates a significant decrease from 76.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.29 in the past 14 days, which was lower than the 1.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.89, while its 200-day Moving Average is $27.87. Now, the first resistance to watch is $26.39. This is followed by the second major resistance level at $26.81. The third major resistance level sits at $27.57. If the price goes on to break the first support level at $25.22, it is likely to go to the next support level at $24.46. Assuming the price breaks the second support level, the third support level stands at $24.04.
Moderna Inc (NASDAQ: MRNA) Key Stats
With a market capitalization of 10.15 billion, the company has a total of 390,734K Shares Outstanding. Currently, annual sales are 3,236 M while annual income is -3,561 M. The company’s previous quarter sales were 1,016 M while its latest quarter income was -200,000 K.
